학술논문

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
Document Type
article
Source
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Subject
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Language
English
ISSN
2051-1426